Posaconazole in lung transplant recipients: use, tolerability, and efficacy

201616 citationsJournal Article

Authors

Chalitha Robinson · Toowoomba Hospital

Chi Hung Chau · University of Queensland

Stephanie T. Yerkovich · Prince Charles Hospital

Maree Azzopardi · Prince Charles Hospital

P. Hopkins · Prince Charles Hospital

Daniel C. Chambers · Prince Charles Hospital

Abstract

PCZ is well tolerated and appears effective in the management of fungal infection after lung transplantation. Patients receiving concurrent tacrolimus require careful therapeutic drug monitoring.

Topics & Keywords

Antifungal resistance and susceptibility Pneumocystis jirovecii pneumonia detection and treatment Fungal Infections and Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplant Infectious Disease

Volume 18, Issue 2, pp. 302-308

DOI: 10.1111/tid.12497

Field-Weighted Citation Impact: 1.51